SILO Pharma (SILO) Competitor Comparison
We are evaluating the key criteria listed to compare SILO Pharma (SILO) against its competitors in the Biotechnology industry.
Market Capitalization
362 / 368Gross Profits
0 / 278Total Revenue
275 / 300EBITDA
0 / 337Free Cashflow
47 / 352Quick Ratio
58 / 357Earnings per Share
146 / 359Dividend yield
0 / 6Total Cash
326 / 358Performance 3 years
329 / 368Performance 5 years
326 / 368Performance 10 years
294 / 368Linearity 3 years
256 / 368Linearity 5 years
265 / 367Linearity 10 years
240 / 368Total Rank
356 / 368Dividend Rank
273 / 368Valuation Rank
232 / 368Piotroski Rank
313 / 368Muliplier Rank
208 / 368Dividend Rank - SILO ranking 273 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.